Emergent BioSolutions
Buying intent
51 tracked signals | Top 15 topics are below | Operations is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Emergent BioSolutions's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
10d ago
26d ago
4d ago
9d ago
17d ago
9d ago
25d ago
15d ago
12d ago
19d ago
25d ago
26d ago
28d ago
28d ago
18d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Emergent BioSolutions
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileAt Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and t
Top accounts researching Emergent BioSolutions
names withheld on the public pageThese are companies whose own people brought up Emergent BioSolutions unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
14,219 companies · 49,122 people are researching Talent Acquisition
Emergent BioSolutions's own team shows 4 signals on this topic. No one outside Emergent BioSolutions has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Clinical Trials3,463 cos · 13,523 people
- Hiring66,174 cos · 318,882 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Finance — 1 person; Security — 1 person; HR / Talent — 1 person; Operations — 1 person
What's been said
public posts by Emergent BioSolutions's teamNo public post naming Emergent BioSolutions has surfaced in the past year, so this is what Emergent BioSolutions's own team is posting about publicly — their topics, in their words.
Excited to be speaking at the Age of AI Conference on May 28 in Toronto! I’ll be joining an expert panel with Dave Makerewich Chrisoula Nikidis Curtis Fichtner on how pharma teams, agencies, and compliance partners can move forward together in the age of AI — balancing innovation, collaboration, and the realities of working in a highly regulated space. Looking forward to discussing different perspectives and how others are navigating how AI is reshaping the industry. If you’re attending, come say hi! #AI #ArtificialIntelligence #Pharma #Pharmaceuticals #LifeSciences #HealthcareInnovation #DigitalHealth #MedTech #Compliance #RegulatoryAffairs #Innovation #FutureOfWork #CustomerExperience #Marketing #PharmaMarketing #Transformation #Leadership #Technology #Toronto #AIinHealthcare #HealthTech #AgencyLife #Biotech
May 2026Looking forward to a productive week at JPM 2026 as we focus on driving future growth. Please reach out if you would like to connect on any partnering opportunities
Jan 2026